Douglas S. Goodin
Research Subjects
Douglas S. Goodin has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
Pouya Khankhanian
Affiliation Kaiser Permanente, Walnut Creek Medical Center, Dublin, California, United States of Ameirca
6 shared publicationsAnthony T Reder
Department of Neurology, the University of Chicago, Chicago, IL, USA
5 shared publicationsVolker Knappertz
Teva Pharmaceuticals, Frazer, Pennsylvania, United States of America, Department of Neurology, Heinrich Heine University, Dusseldorf, Germany
5 shared publicationsGary Cutter
Department of Biostatistics, UAB School of Public Health, Birmingham, AL, USA
4 shared publicationsKarola Beckmann
Bayer HealthCare Pharmaceuticals, Wayne, New Jersey, USA
4 shared publications- Nicolas Vince
Nantes Université
4 shared publications
Latest Publications
- Open Access
- 27 February 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 22 (4) , e00539
The epidemiology, pathology and pathogenesis of MS: Therapeutic implications
- 27 February 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 22 (4) , e00539
Open AccessThe epidemiology, pathology and pathogenesis of MS: Therapeutic implications
- Open Access
- 2 July 2024
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 95 (11) , 1002-1011
Pathogenesis of multiple sclerosis: genetic, environmental and random mechanisms
Background: The pathogenesis of multiple sclerosis (MS) requires both genetic factors and environmental events. The question remains, however, whether these factors and events completely describe the MS disease process. This question was addressed using the Canadian MS data, which includes 29 478 individuals, estimated to represent 65–83% of all Canadian patients with MS.Method: The ‘genetically-susceptible’ subset of the population, (G), includes everyone who has any non-zero life-time chance of developing MS, under some environmental conditions. A ‘sufficient’ environmental exposure, for any genetically-susceptible individual, includes every set of environmental conditions, each of which is ‘sufficient’, by itself, tocauseMS in that person. This analysis incorporates many epidemiological parameters, involved in MS pathogenesis, only some of which are directly observable, and establishes ‘plausible’ value ranges for each parameter. Those parameter value combinations (ie, solutions) that fall within these plausible ranges are then determined.Results: Only a small proportion of the population (≤52%) has any possibility of developing MS, regardless of any environmental conditions that they could experience. Moreover, some of these genetically-susceptible individuals, despite their experiencing a ‘sufficient’ environmental exposure, will still not develop disease.Conclusions: This analysis explicitly includes all of those genetic factors and environmental events (including their interactions), which are necessary for MS pathogenesis, regardless of whether these factors, events and interactions are known, suspected or as yet unrecognised. Nevertheless, in addition, a ‘truly’ random mechanism also seems to play a critical role in disease pathogenesis. This observation provides empirical evidence, which undermines the widely-held deterministic view of nature. Moreover, both sexes seem to share a similar genetic and environmental disease basis. If so, then it is this random mechanism, which is primarily responsible for the currently-observed differences in MS disease expression betweensusceptible womenandsusceptible men.
- 2 July 2024
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 95 (11) , 1002-1011
Open AccessPathogenesis of multiple sclerosis: genetic, environmental and random mechanisms
Background: The pathogenesis of multiple sclerosis (MS) requires both genetic factors and environmental events. The question remains, however, whether these factors and events completely describe the MS disease process. This question was addressed using the Canadian MS data, which includes 29 478 individuals, estimated to represent 65–83% of all Canadian patients with MS.Method: The ‘genetically-susceptible’ subset of the population, (G), includes everyone who has any non-zero life-time chance of developing MS, under some environmental conditions. A ‘sufficient’ environmental exposure, for any genetically-susceptible individual, includes every set of environmental conditions, each of which is ‘sufficient’, by itself, tocauseMS in that person. This analysis incorporates many epidemiological parameters, involved in MS pathogenesis, only some of which are directly observable, and establishes ‘plausible’ value ranges for each parameter. Those parameter value combinations (ie, solutions) that fall within these plausible ranges are then determined.Results: Only a small proportion of the population (≤52%) has any possibility of developing MS, regardless of any environmental conditions that they could experience. Moreover, some of these genetically-susceptible individuals, despite their experiencing a ‘sufficient’ environmental exposure, will still not develop disease.Conclusions: This analysis explicitly includes all of those genetic factors and environmental events (including their interactions), which are necessary for MS pathogenesis, regardless of whether these factors, events and interactions are known, suspected or as yet unrecognised. Nevertheless, in addition, a ‘truly’ random mechanism also seems to play a critical role in disease pathogenesis. This observation provides empirical evidence, which undermines the widely-held deterministic view of nature. Moreover, both sexes seem to share a similar genetic and environmental disease basis. If so, then it is this random mechanism, which is primarily responsible for the currently-observed differences in MS disease expression betweensusceptible womenandsusceptible men.
- Open Access
Pathogenesis of Multiple Sclerosis: Genetic, Environmental, and Random Mechanisms
BACKGROUND: MS-pathogenesis requires both genetic factors and environmental events. The question remains, however, whether these factors and events completely describe the MS disease-process. This question was addressed using the Canadian MS-data, which includes 29,478 individuals, representing 65-83% of all Canadian MS-patients. METHODS: The “ genetically-susceptible ” subset of the population, ( G ), includes everyone who has any non-zero life-time chance of developing MS, under some environmental-conditions. A “ sufficient ” environmental-exposure, for any “ genetically-susceptible ” individual, includes every set of environmental conditions, each of which is sufficient , by itself, to cause MS in that person. This analysis incorporates several different epidemiologic-parameters , involved in MS-pathogenesis, only some of which are directly-observable, and establishes “ plausible-value-ranges” for each parameter. Those parameter-value combinations (solutions) that fall within these plausible-ranges are then determined. RESULTS: Only a fraction of the population can possibly be “ genetically-susceptible ”. Thus, many individuals have no possibility of developing MS under any environmental conditions. Moreover, some “ genetically-susceptible ” individuals, despite their experiencing a “ sufficient ” environmental-exposure, will never develop disease. CONCLUSIONS: This analysis explicitly includes all of those genetic factors and environmental events (including interactions), which are necessary for MS-pathogenesis, regardless of whether these are known, suspected, or as yet unrecognized. Nevertheless, in addition, “ true ” randomness seems to play a critical role in disease-pathogenesis. This observation provides empirical evidence that undermines the widely-held deterministic view of nature. Moreover, both sexes seem to have a similar genetic and environmental disease-basis. If so, this indicates that this random element is primarily responsible for the currently-observed differences in disease-expression between susceptible-women and susceptible-men .
Open AccessPathogenesis of Multiple Sclerosis: Genetic, Environmental, and Random Mechanisms
BACKGROUND: MS-pathogenesis requires both genetic factors and environmental events. The question remains, however, whether these factors and events completely describe the MS disease-process. This question was addressed using the Canadian MS-data, which includes 29,478 individuals, representing 65-83% of all Canadian MS-patients. METHODS: The “ genetically-susceptible ” subset of the population, ( G ), includes everyone who has any non-zero life-time chance of developing MS, under some environmental-conditions. A “ sufficient ” environmental-exposure, for any “ genetically-susceptible ” individual, includes every set of environmental conditions, each of which is sufficient , by itself, to cause MS in that person. This analysis incorporates several different epidemiologic-parameters , involved in MS-pathogenesis, only some of which are directly-observable, and establishes “ plausible-value-ranges” for each parameter. Those parameter-value combinations (solutions) that fall within these plausible-ranges are then determined. RESULTS: Only a fraction of the population can possibly be “ genetically-susceptible ”. Thus, many individuals have no possibility of developing MS under any environmental conditions. Moreover, some “ genetically-susceptible ” individuals, despite their experiencing a “ sufficient ” environmental-exposure, will never develop disease. CONCLUSIONS: This analysis explicitly includes all of those genetic factors and environmental events (including interactions), which are necessary for MS-pathogenesis, regardless of whether these are known, suspected, or as yet unrecognized. Nevertheless, in addition, “ true ” randomness seems to play a critical role in disease-pathogenesis. This observation provides empirical evidence that undermines the widely-held deterministic view of nature. Moreover, both sexes seem to have a similar genetic and environmental disease-basis. If so, this indicates that this random element is primarily responsible for the currently-observed differences in disease-expression between susceptible-women and susceptible-men .
- Open Access
- 28 June 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0285599
Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility
Objective: To explore and describe the basis and implications of genetic and environmental susceptibility to multiple sclerosis (MS) using the Canadian population-based data.Background: Certain parameters of MS-epidemiology are directly observable (e.g., the recurrence-risk of MS in siblings and twins, the proportion ofwomenamong MS patients, the population-prevalence of MS, and the time-dependent changes in thesex-ratio). By contrast, other parameters can only be inferred from the observed parameters (e.g., the proportion of the population that is “genetically susceptible”, the proportion ofwomenamong susceptible individuals, the probability that a susceptible individual will experience an environment “sufficient” to cause MS, and if they do, the probability that they will develop the disease).Design/methods: The “genetically susceptible” subset (G) of the population (Z) is defined to include everyone withanynon-zero life-time chance of developing MS undersomeenvironmental conditions. The value for each observed and non-observed epidemiological parameter is assigned a “plausible” range. Using both aCross-sectional Modeland aLongitudinal Model, together with established parameter relationships, we explore, iteratively, trillions of potential parameter combinations and determine those combinations (i.e., solutions) that fall within the acceptable range for both the observed and non-observed parameters.Results: BothModelsand all analyses intersect and converge to demonstrate that probability of genetic-susceptibitly,P(G), is limited to only a fraction of the population {i.e.,P(G) ≤ 0.52)} and an even smaller fraction ofwomen{i.e.,P(G│F) < 0.32)}. Consequently, most individuals (particularlywomen) have no chance whatsoever of developing MS, regardless of their environmental exposure. However, for any susceptible individual to develop MS,requiresthat they also experience a “sufficient” environment. We use the Canadian data to derive, separately, the exponential response-curves formenandwomenthat relate the increasing likelihood of developing MS to an increasing probability that a susceptible individual experiences an environment “sufficient” to cause MS. As the probability of a “sufficient” exposure increases, we define, separately, the limiting probability of developing MS inmen(c) andwomen(d). These Canadian data strongly suggest that: (c<d≤ 1). If so, this observation establishes both that there must be a “truly” random factor involved in MS pathogenesis and that it is this difference, rather than any difference in genetic or environmental factors, which primarily accounts for thepenetrancedifference betweenwomenandmen.Conclusions: The development of MS (in an individual) requires both that they have an appropriate genotype (which is uncommon in the population) and that they have an environmental exposure “sufficient” to cause MS given their genotype. Nevertheless, the two principal findings of this study are that:P(G) ≤ 0.52)} and: (c<d≤ 1). Threfore, even when the necessary genetic and environmental factors, “sufficient” for MS pathogenesis, co-occur for an individual, they still may or may not develop MS. Consequently, disease pathogenesis, even in this circumstance, seems to involve an important element of chance. Moreover, the conclusion that the macroscopic process of disease development for MS includes a “truly” random element, if replicated (either for MS or for other complex diseases), provides empiric evidence that our universe is non-deterministic.
- 28 June 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0285599
Open AccessMultiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility
Objective: To explore and describe the basis and implications of genetic and environmental susceptibility to multiple sclerosis (MS) using the Canadian population-based data.Background: Certain parameters of MS-epidemiology are directly observable (e.g., the recurrence-risk of MS in siblings and twins, the proportion ofwomenamong MS patients, the population-prevalence of MS, and the time-dependent changes in thesex-ratio). By contrast, other parameters can only be inferred from the observed parameters (e.g., the proportion of the population that is “genetically susceptible”, the proportion ofwomenamong susceptible individuals, the probability that a susceptible individual will experience an environment “sufficient” to cause MS, and if they do, the probability that they will develop the disease).Design/methods: The “genetically susceptible” subset (G) of the population (Z) is defined to include everyone withanynon-zero life-time chance of developing MS undersomeenvironmental conditions. The value for each observed and non-observed epidemiological parameter is assigned a “plausible” range. Using both aCross-sectional Modeland aLongitudinal Model, together with established parameter relationships, we explore, iteratively, trillions of potential parameter combinations and determine those combinations (i.e., solutions) that fall within the acceptable range for both the observed and non-observed parameters.Results: BothModelsand all analyses intersect and converge to demonstrate that probability of genetic-susceptibitly,P(G), is limited to only a fraction of the population {i.e.,P(G) ≤ 0.52)} and an even smaller fraction ofwomen{i.e.,P(G│F) < 0.32)}. Consequently, most individuals (particularlywomen) have no chance whatsoever of developing MS, regardless of their environmental exposure. However, for any susceptible individual to develop MS,requiresthat they also experience a “sufficient” environment. We use the Canadian data to derive, separately, the exponential response-curves formenandwomenthat relate the increasing likelihood of developing MS to an increasing probability that a susceptible individual experiences an environment “sufficient” to cause MS. As the probability of a “sufficient” exposure increases, we define, separately, the limiting probability of developing MS inmen(c) andwomen(d). These Canadian data strongly suggest that: (c<d≤ 1). If so, this observation establishes both that there must be a “truly” random factor involved in MS pathogenesis and that it is this difference, rather than any difference in genetic or environmental factors, which primarily accounts for thepenetrancedifference betweenwomenandmen.Conclusions: The development of MS (in an individual) requires both that they have an appropriate genotype (which is uncommon in the population) and that they have an environmental exposure “sufficient” to cause MS given their genotype. Nevertheless, the two principal findings of this study are that:P(G) ≤ 0.52)} and: (c<d≤ 1). Threfore, even when the necessary genetic and environmental factors, “sufficient” for MS pathogenesis, co-occur for an individual, they still may or may not develop MS. Consequently, disease pathogenesis, even in this circumstance, seems to involve an important element of chance. Moreover, the conclusion that the macroscopic process of disease development for MS includes a “truly” random element, if replicated (either for MS or for other complex diseases), provides empiric evidence that our universe is non-deterministic.
- Open Access
- 9 August 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0254945
Genetic susceptibility to multiple sclerosis in African Americans
Objective: To explore the nature of genetic-susceptibility to multiple sclerosis (MS) in African-Americans. Background: Recently, the number of genetic-associations with MS has exploded although the MS-associations of specific haplotypes within the major histocompatibility complex (MHC) have been known for decades. For example, the haplotypes HLA-DRB1*15:01~HLA-DQB1*06:02, and HLA-DRB1*03:01~ HLA-DQB1*02:01 have odds ratios (ORs) for an MS-association orders of magnitude stronger than many of these newly-discovered associations. Nevertheless, all these haplotypes are part of much larger conserved extended haplotypes (CEHs), which span both the Class I and Class II MHC regions. African-Americans are at greater risk of developing MS compared to a native Africans but at lesser risk compared to Europeans. It is the purpose of this manuscript to explore the relationship between MS-susceptibility and the CEH make-up of our African-American cohort. Design/methods: The African-American (AA) cohort consisted of 1,305 patients with MS and 1,155 controls, who self-identified as being African-American. For comparison, we used the 18,492 controls and 11,144 MS-cases from the predominantly European Wellcome Trust Case Control Consortium (WTCCC) and the 28,557 phased native Africans from the multinational “Be the Match” registry. The WTCCC and the African-Americans were phased at each of five HLA loci (HLA-A, HLA-C, HLA-B, HLA-DRB1 and HLA-DQB1) and the at 11 SNPs (10 of which were in non-coding regions) surrounding the Class II region of the DRB1 gene using previously-published probabilistic phasing algorithms. Results: Of the 32 most frequent CEHs, 18 (56%) occurred either more frequently or exclusively in Africans) whereas 9 (28%) occurred more frequently or exclusively in Europeans. The remaining 5 CEHs occurred in neither control group although, likely, these were African in origin. Eight of these CEHs carried the DRB1*15:03~DQB1*06:02~a36 haplotype and three carried the DRB1*15:01~DQB1*06:02~a1 haplotype. In African Americans, a single-copy of the European CEH (03:01_07:02_07:02_15:01_06:02_a1) was associated with considerable MS-risk (OR = 3.30; p = 0.0001)–similar to that observed in the WTCCC (OR = 3.25; p−168). By contrast, the MS-risk for the European CEH (02:01_07:02_07:02_15:01_06:02_a1) was less (OR = 1.49; ns)–again, similar to the WTCCC (OR = 2.2; p−38). Moreover, four African haplotypes were “protective” relative to a neutral reference, to three European CEHs, and also to the five other African CEHs. Conclusions: The common CEHs in African Americans are divisible into those that are either African or European in origin, which are derived without modification from their source population. European CEHs, linked to MS-risk, in general, had similar impacts in African-Americans as they did in Europeans. By contrast, African CEHs had mixed MS-risks. For a few, the MS-risk exceeded that in a neutral-reference group whereas, for many others, these CEHs were “protective”–perhaps providing a partial rationale for the lower MS-risk in African-Americans compared to European-Americans.
- 9 August 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0254945
Open AccessGenetic susceptibility to multiple sclerosis in African Americans
Objective: To explore the nature of genetic-susceptibility to multiple sclerosis (MS) in African-Americans. Background: Recently, the number of genetic-associations with MS has exploded although the MS-associations of specific haplotypes within the major histocompatibility complex (MHC) have been known for decades. For example, the haplotypes HLA-DRB1*15:01~HLA-DQB1*06:02, and HLA-DRB1*03:01~ HLA-DQB1*02:01 have odds ratios (ORs) for an MS-association orders of magnitude stronger than many of these newly-discovered associations. Nevertheless, all these haplotypes are part of much larger conserved extended haplotypes (CEHs), which span both the Class I and Class II MHC regions. African-Americans are at greater risk of developing MS compared to a native Africans but at lesser risk compared to Europeans. It is the purpose of this manuscript to explore the relationship between MS-susceptibility and the CEH make-up of our African-American cohort. Design/methods: The African-American (AA) cohort consisted of 1,305 patients with MS and 1,155 controls, who self-identified as being African-American. For comparison, we used the 18,492 controls and 11,144 MS-cases from the predominantly European Wellcome Trust Case Control Consortium (WTCCC) and the 28,557 phased native Africans from the multinational “Be the Match” registry. The WTCCC and the African-Americans were phased at each of five HLA loci (HLA-A, HLA-C, HLA-B, HLA-DRB1 and HLA-DQB1) and the at 11 SNPs (10 of which were in non-coding regions) surrounding the Class II region of the DRB1 gene using previously-published probabilistic phasing algorithms. Results: Of the 32 most frequent CEHs, 18 (56%) occurred either more frequently or exclusively in Africans) whereas 9 (28%) occurred more frequently or exclusively in Europeans. The remaining 5 CEHs occurred in neither control group although, likely, these were African in origin. Eight of these CEHs carried the DRB1*15:03~DQB1*06:02~a36 haplotype and three carried the DRB1*15:01~DQB1*06:02~a1 haplotype. In African Americans, a single-copy of the European CEH (03:01_07:02_07:02_15:01_06:02_a1) was associated with considerable MS-risk (OR = 3.30; p = 0.0001)–similar to that observed in the WTCCC (OR = 3.25; p−168). By contrast, the MS-risk for the European CEH (02:01_07:02_07:02_15:01_06:02_a1) was less (OR = 1.49; ns)–again, similar to the WTCCC (OR = 2.2; p−38). Moreover, four African haplotypes were “protective” relative to a neutral reference, to three European CEHs, and also to the five other African CEHs. Conclusions: The common CEHs in African Americans are divisible into those that are either African or European in origin, which are derived without modification from their source population. European CEHs, linked to MS-risk, in general, had similar impacts in African-Americans as they did in Europeans. By contrast, African CEHs had mixed MS-risks. For a few, the MS-risk exceeded that in a neutral-reference group whereas, for many others, these CEHs were “protective”–perhaps providing a partial rationale for the lower MS-risk in African-Americans compared to European-Americans.
- Open Access
- 10 July 2021
- Published by Springer Nature in BMC Medical Genomics
- Vol. 14 (1) , 1-15
Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions
Background: To study the accumulation of MS-risk resulting from different combinations of MS-associated conserved-extended-haplotypes (CEHs) of theMHCand three non-MHC“risk-haplotypes” nearby genesEOMES, ZFP36L1,andCLEC16A. Many haplotypes are MS-associated despite having population-frequencies exceeding the percentage of genetically-susceptible individuals. The basis of this frequency-disparity requires explanation.Methods: TheSNP-data from the WTCCC was phased at theMHCand three non-MHCsusceptibility-regions.CEHsat theMHCwere classified into five haplotype-groups: (HLA-DRB1*15:01 ~ DQB1*06:02 ~ a1)-containing (H +); extended-risk (ER); all-protective (AP); neutral (0); and the single-CEH(c1). MS-associations for different “risk-combinations” at theMHCand other non-MHC“risk-loci” and the appropriateness of additive and multiplicative risk-accumulation models were assessed.Results: Different combinations of “risk-haplotypes” produce a final MS-risk closer to additive rather than multiplicative risk-models but neither model was consistent. Thus, (H +)-haplotypes had greater impact when combined with (0)-haplotypes than with (H +)-haplotypes, whereas, (H +)-haplotypes had greater impact when combined with a (c1)-haplotypes than with (0)-haplotypes. Similarly, risk-genotypes (0,H +), (c1,H +), (H + ,H +) and (0,c1) were additive with risks from non-MHCrisk-loci, whereas risk-genotypes (ER,H +) and (AP,c1) were unaffected.Conclusions: Genetic-susceptibility to MS is essential for MS to develop but actually developing MS depends heavily upon both an individual’s particular combination of “risk-haplotypes” and how these loci interact.
- 10 July 2021
- Published by Springer Nature in BMC Medical Genomics
- Vol. 14 (1) , 1-15
Open AccessGenetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions
Background: To study the accumulation of MS-risk resulting from different combinations of MS-associated conserved-extended-haplotypes (CEHs) of theMHCand three non-MHC“risk-haplotypes” nearby genesEOMES, ZFP36L1,andCLEC16A. Many haplotypes are MS-associated despite having population-frequencies exceeding the percentage of genetically-susceptible individuals. The basis of this frequency-disparity requires explanation.Methods: TheSNP-data from the WTCCC was phased at theMHCand three non-MHCsusceptibility-regions.CEHsat theMHCwere classified into five haplotype-groups: (HLA-DRB1*15:01 ~ DQB1*06:02 ~ a1)-containing (H +); extended-risk (ER); all-protective (AP); neutral (0); and the single-CEH(c1). MS-associations for different “risk-combinations” at theMHCand other non-MHC“risk-loci” and the appropriateness of additive and multiplicative risk-accumulation models were assessed.Results: Different combinations of “risk-haplotypes” produce a final MS-risk closer to additive rather than multiplicative risk-models but neither model was consistent. Thus, (H +)-haplotypes had greater impact when combined with (0)-haplotypes than with (H +)-haplotypes, whereas, (H +)-haplotypes had greater impact when combined with a (c1)-haplotypes than with (0)-haplotypes. Similarly, risk-genotypes (0,H +), (c1,H +), (H + ,H +) and (0,c1) were additive with risks from non-MHCrisk-loci, whereas risk-genotypes (ER,H +) and (AP,c1) were unaffected.Conclusions: Genetic-susceptibility to MS is essential for MS to develop but actually developing MS depends heavily upon both an individual’s particular combination of “risk-haplotypes” and how these loci interact.
- Open Access
- 22 March 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3) , e0246157
The nature of genetic and environmental susceptibility to multiple sclerosis
Objective: To understand the nature of genetic and environmental susceptibility to multiple sclerosis (MS) and, by extension, susceptibility to other complex genetic diseases. Background: Certain basic epidemiological parameters of MS (e.g., population-prevalence of MS, recurrence-risks for MS in siblings and twins, proportion of women among MS patients, and the time-dependent changes in the sex-ratio) are well-established. In addition, more than 233 genetic-loci have now been identified as being unequivocally MS-associated, including 32 loci within the major histocompatibility complex (MHC), and one locus on the X chromosome. Despite this recent explosion in genetic associations, however, the association of MS with the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 (H+) haplotype has been known for decades. Design/Methods: We define the “genetically-susceptible” subset (G) to include everyone with any non-zero life-time chance of developing MS. Individuals who have no chance of developing MS, regardless of their environmental experiences, belong to the mutually exclusive “non-susceptible” subset (G–). Using these well-established epidemiological parameters, we analyze, mathematically, the implications that these observations have regarding the genetic-susceptibility to MS. In addition, we use the sex-ratio change (observed over a 35-year interval in Canada), to derive the relationship between MS-probability and an increasing likelihood of a sufficient environmental exposure. Results: We demonstrate that genetic-susceptibitly is confined to less than 7.3% of populations throughout Europe and North America. Consequently, more than 92.7% of individuals in these populations have no chance whatsoever of developing MS, regardless of their environmental experiences. Even among carriers of the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 haplotype, far fewer than 32% can possibly be members the (G) subset. Also, despite the current preponderance of women among MS patients, women are less likely to be in the susceptible (G) subset and have a higher environmental threshold for developing MS compared to men. Nevertheless, the penetrance of MS in susceptible women is considerably greater than it is in men. Moreover, the response-curves for MS-probability in susceptible individuals increases with an increasing likelihood of a sufficient environmental exposure, especially among women. However, these environmental response-curves plateau at under 50% for women and at a significantly lower level for men. Conclusions: The pathogenesis of MS requires both a genetic predisposition and a suitable environmental exposure. Nevertheless, genetic-susceptibility is rare in the population (< 7.3%) and requires specific combinations of non-additive genetic risk-factors. For example, only a minority of carriers of the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 haplotype are even in the (G) subset and, thus, genetic-susceptibility to MS in these carriers must result from the combined effect this haplotype together with the effects of certain other (as yet, unidentified) genetic factors. By itself, this haplotype poses no MS-risk. By contrast, a sufficient environmental exposure (however many events are involved, whenever these events need to act, and whatever these events might be) is common, currently occurring in, at least, 76% of susceptible individuals. In addition, the fact that environmental response-curves plateau well below 50% (especially in men), indicates that disease pathogenesis is partly stochastic. By extension, other diseases, for which monozygotic-twin recurrence-risks greatly exceed the disease-prevalence (e.g., rheumatoid arthritis, diabetes, and celiac disease), must have a similar genetic basis.
- 22 March 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3) , e0246157
Open AccessThe nature of genetic and environmental susceptibility to multiple sclerosis
Objective: To understand the nature of genetic and environmental susceptibility to multiple sclerosis (MS) and, by extension, susceptibility to other complex genetic diseases. Background: Certain basic epidemiological parameters of MS (e.g., population-prevalence of MS, recurrence-risks for MS in siblings and twins, proportion of women among MS patients, and the time-dependent changes in the sex-ratio) are well-established. In addition, more than 233 genetic-loci have now been identified as being unequivocally MS-associated, including 32 loci within the major histocompatibility complex (MHC), and one locus on the X chromosome. Despite this recent explosion in genetic associations, however, the association of MS with the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 (H+) haplotype has been known for decades. Design/Methods: We define the “genetically-susceptible” subset (G) to include everyone with any non-zero life-time chance of developing MS. Individuals who have no chance of developing MS, regardless of their environmental experiences, belong to the mutually exclusive “non-susceptible” subset (G–). Using these well-established epidemiological parameters, we analyze, mathematically, the implications that these observations have regarding the genetic-susceptibility to MS. In addition, we use the sex-ratio change (observed over a 35-year interval in Canada), to derive the relationship between MS-probability and an increasing likelihood of a sufficient environmental exposure. Results: We demonstrate that genetic-susceptibitly is confined to less than 7.3% of populations throughout Europe and North America. Consequently, more than 92.7% of individuals in these populations have no chance whatsoever of developing MS, regardless of their environmental experiences. Even among carriers of the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 haplotype, far fewer than 32% can possibly be members the (G) subset. Also, despite the current preponderance of women among MS patients, women are less likely to be in the susceptible (G) subset and have a higher environmental threshold for developing MS compared to men. Nevertheless, the penetrance of MS in susceptible women is considerably greater than it is in men. Moreover, the response-curves for MS-probability in susceptible individuals increases with an increasing likelihood of a sufficient environmental exposure, especially among women. However, these environmental response-curves plateau at under 50% for women and at a significantly lower level for men. Conclusions: The pathogenesis of MS requires both a genetic predisposition and a suitable environmental exposure. Nevertheless, genetic-susceptibility is rare in the population (< 7.3%) and requires specific combinations of non-additive genetic risk-factors. For example, only a minority of carriers of the HLA-DRB1*15:01~HLA-DQB1*06:02~a1 haplotype are even in the (G) subset and, thus, genetic-susceptibility to MS in these carriers must result from the combined effect this haplotype together with the effects of certain other (as yet, unidentified) genetic factors. By itself, this haplotype poses no MS-risk. By contrast, a sufficient environmental exposure (however many events are involved, whenever these events need to act, and whatever these events might be) is common, currently occurring in, at least, 76% of susceptible individuals. In addition, the fact that environmental response-curves plateau well below 50% (especially in men), indicates that disease pathogenesis is partly stochastic. By extension, other diseases, for which monozygotic-twin recurrence-risks greatly exceed the disease-prevalence (e.g., rheumatoid arthritis, diabetes, and celiac disease), must have a similar genetic basis.
- 25 November 2020
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 27 (9) , 1432-1441
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis
In persons with multiple sclerosis (MS), the Expanded Disability Status Scale (EDSS) is the criterion standard for assessing disability, but its in-person nature constrains patient participation in research and clinical assessments. The aim of this study was to develop and validate a scalable, electronic, unsupervised patient-reported EDSS (ePR-EDSS) that would capture MS-related disability across the spectrum of severity. We enrolled 136 adult MS patients, split into a preliminary testing Cohort 1 (n = 50), and a validation Cohort 2 (n = 86), which was evenly distributed across EDSS groups. Each patient completed an ePR-EDSS either immediately before or after a MS clinician’s Neurostatus EDSS evaluation. In Cohort 2, mean age was 50.6 years (range = 26–80) and median EDSS was 3.5 (interquartile range (IQR) = [1.5, 5.5]). The ePR-EDSS and EDSS agreed within 1-point for 86% of examinations; kappa for agreement within 1-point was 0.85 (p < 0.001). The correlation coefficient between the two measures was 0.91 (<0.001). The ePR-EDSS was highly correlated with EDSS, with good agreement even at lower EDSS levels. For clinical care, the ePR-EDSS could enable the longitudinal monitoring of a patient’s disability. For research, it provides a valid and rapid measure across the entire spectrum of disability and permits broader participation with fewer in-person assessments.
- 25 November 2020
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 27 (9) , 1432-1441
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis
In persons with multiple sclerosis (MS), the Expanded Disability Status Scale (EDSS) is the criterion standard for assessing disability, but its in-person nature constrains patient participation in research and clinical assessments. The aim of this study was to develop and validate a scalable, electronic, unsupervised patient-reported EDSS (ePR-EDSS) that would capture MS-related disability across the spectrum of severity. We enrolled 136 adult MS patients, split into a preliminary testing Cohort 1 (n = 50), and a validation Cohort 2 (n = 86), which was evenly distributed across EDSS groups. Each patient completed an ePR-EDSS either immediately before or after a MS clinician’s Neurostatus EDSS evaluation. In Cohort 2, mean age was 50.6 years (range = 26–80) and median EDSS was 3.5 (interquartile range (IQR) = [1.5, 5.5]). The ePR-EDSS and EDSS agreed within 1-point for 86% of examinations; kappa for agreement within 1-point was 0.85 (p < 0.001). The correlation coefficient between the two measures was 0.91 (<0.001). The ePR-EDSS was highly correlated with EDSS, with good agreement even at lower EDSS levels. For clinical care, the ePR-EDSS could enable the longitudinal monitoring of a patient’s disability. For research, it provides a valid and rapid measure across the entire spectrum of disability and permits broader participation with fewer in-person assessments.
- Open Access
- 5 November 2020
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 41 (12) , 2219-2226
Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS
BACKGROUND AND PURPOSE: MR imaging is essential for MS diagnosis and management, yet it has limitations in assessing axonal damage and remyelination. Gadolinium-based contrast agents add value by pinpointing acute inflammation and blood-brain barrier leakage, but with drawbacks in safety and cost. Neurite orientation dispersion and density imaging (NODDI) assesses microstructural features of neurites contributing to diffusion imaging signals. This approach may resolve the components of MS pathology, overcoming conventional MR imaging limitations. MATERIALS AND METHODS: Twenty-one subjects with MS underwent serial enhanced MRIs (12.6 ± 9 months apart) including NODDI, whose key metrics are the neurite density and orientation dispersion index. Twenty-one age- and sex-matched healthy controls underwent unenhanced MR imaging with the same protocol. Fifty-eight gadolinium-enhancing and non-gadolinium-enhancing lesions were semiautomatically segmented at baseline and follow-up. Normal-appearing WM masks were generated by subtracting lesions and dirty-appearing WM from the whole WM. RESULTS: The orientation dispersion index was higher in gadolinium-enhancing compared with non-gadolinium-enhancing lesions; logistic regression indicated discrimination, with an area under the curve of 0.73. At follow-up, in the 58 previously enhancing lesions, we identified 2 subgroups based on the neurite density index change across time: Type 1 lesions showed increased neurite density values, whereas type 2 lesions showed decreased values. Type 1 lesions showed greater reduction in size with time compared with type 2 lesions. CONCLUSIONS: NODDI is a promising tool with the potential to detect acute MS inflammation. The observed heterogeneity among lesions may correspond to gradients in severity and clinical recovery after the acute phase.
- 5 November 2020
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 41 (12) , 2219-2226
Open AccessNeurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS
BACKGROUND AND PURPOSE: MR imaging is essential for MS diagnosis and management, yet it has limitations in assessing axonal damage and remyelination. Gadolinium-based contrast agents add value by pinpointing acute inflammation and blood-brain barrier leakage, but with drawbacks in safety and cost. Neurite orientation dispersion and density imaging (NODDI) assesses microstructural features of neurites contributing to diffusion imaging signals. This approach may resolve the components of MS pathology, overcoming conventional MR imaging limitations. MATERIALS AND METHODS: Twenty-one subjects with MS underwent serial enhanced MRIs (12.6 ± 9 months apart) including NODDI, whose key metrics are the neurite density and orientation dispersion index. Twenty-one age- and sex-matched healthy controls underwent unenhanced MR imaging with the same protocol. Fifty-eight gadolinium-enhancing and non-gadolinium-enhancing lesions were semiautomatically segmented at baseline and follow-up. Normal-appearing WM masks were generated by subtracting lesions and dirty-appearing WM from the whole WM. RESULTS: The orientation dispersion index was higher in gadolinium-enhancing compared with non-gadolinium-enhancing lesions; logistic regression indicated discrimination, with an area under the curve of 0.73. At follow-up, in the 58 previously enhancing lesions, we identified 2 subgroups based on the neurite density index change across time: Type 1 lesions showed increased neurite density values, whereas type 2 lesions showed decreased values. Type 1 lesions showed greater reduction in size with time compared with type 2 lesions. CONCLUSIONS: NODDI is a promising tool with the potential to detect acute MS inflammation. The observed heterogeneity among lesions may correspond to gradients in severity and clinical recovery after the acute phase.
- Open Access
- 6 October 2020
- Published by Springer Nature in Research Square
Genetic Susceptibility to Multiple Sclerosis: Interactions between Conserved Extended Haplotypes of the MHC and other Susceptibility Regions
BACKGROUNDTo study the accumulation of MS-risk resulting from different combinations of MS-associated conserved-extended-haplotypes (CEHs) of the MHC and three non-MHC “risk-haplotypes” nearby genes EOMES, ZFP36L1, and CLEC16A. Many haplotypes are MS-associated despite having population-frequencies exceeding the percentage of genetically-susceptible individuals. The basis of this frequency-disparity requires explanation. MEHTODSWTCCC SNP-data was phased at the MHC and three non-MHC susceptibility-regions. CEHs at the MHC were classified into five haplotype-groups: (HLA-DRB1*15:01~DQB1*06:02~a1)-containing (H+); extended-risk (ER); all-protective (AP); neutral (0); and the single-CEH (c1). MS-associations for different “risk-combinations” at the MHC and other non-MHC “risk-loci” and the appropriateness of additive and multiplicative risk-accumulation models were assessed.RESULTSDifferent combinations of “risk-haplotypes” produce a final MS-risk closer to additive rather than multiplicative risk-models but neither model was consistent. Thus, (H+)-haplotypes had greater impact when combined with (0)-haplotypes than with (H+)-haplotypes, whereas, (H+)-haplotypes had greater impact when combined with a (c1)-haplotypes than with (0)-haplotypes. Similarly, risk-genotypes (0,H+), (c1,H+), (H+,H+) and (0,c1) were additive with risks from non-MHC risk-loci, whereas risk-genotypes (ER,H+) and (AP,c1) were unaffected.CONCLUSIONSGenetic-susceptibility to MS is essential for MS to develop but actually developing MS depends heavily upon both an individual’s particular combination of “risk-haplotypes” and how these loci interact.
- 6 October 2020
- Published by Springer Nature in Research Square
Open AccessGenetic Susceptibility to Multiple Sclerosis: Interactions between Conserved Extended Haplotypes of the MHC and other Susceptibility Regions
BACKGROUNDTo study the accumulation of MS-risk resulting from different combinations of MS-associated conserved-extended-haplotypes (CEHs) of the MHC and three non-MHC “risk-haplotypes” nearby genes EOMES, ZFP36L1, and CLEC16A. Many haplotypes are MS-associated despite having population-frequencies exceeding the percentage of genetically-susceptible individuals. The basis of this frequency-disparity requires explanation. MEHTODSWTCCC SNP-data was phased at the MHC and three non-MHC susceptibility-regions. CEHs at the MHC were classified into five haplotype-groups: (HLA-DRB1*15:01~DQB1*06:02~a1)-containing (H+); extended-risk (ER); all-protective (AP); neutral (0); and the single-CEH (c1). MS-associations for different “risk-combinations” at the MHC and other non-MHC “risk-loci” and the appropriateness of additive and multiplicative risk-accumulation models were assessed.RESULTSDifferent combinations of “risk-haplotypes” produce a final MS-risk closer to additive rather than multiplicative risk-models but neither model was consistent. Thus, (H+)-haplotypes had greater impact when combined with (0)-haplotypes than with (H+)-haplotypes, whereas, (H+)-haplotypes had greater impact when combined with a (c1)-haplotypes than with (0)-haplotypes. Similarly, risk-genotypes (0,H+), (c1,H+), (H+,H+) and (0,c1) were additive with risks from non-MHC risk-loci, whereas risk-genotypes (ER,H+) and (AP,c1) were unaffected.CONCLUSIONSGenetic-susceptibility to MS is essential for MS to develop but actually developing MS depends heavily upon both an individual’s particular combination of “risk-haplotypes” and how these loci interact.